End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.5 TWD | -1.98% |
|
+4.20% | +66.67% |
May. 15 | Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 387
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Technical Services
99.8
%
| 615 | 84.0 % | 652 | 99.8 % | +5.96% |
Other
0.2
%
| 117 | 16.0 % | 1 | 0.2 % | -99.05% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
75.7
%
| 326 | 44.5 % | 494 | 75.7 % | +51.66% |
Taiwan
23.9
%
| 278 | 38.0 % | 156 | 23.9 % | -43.87% |
America
0.4
%
| 7 | 1.0 % | 3 | 0.4 % | -61.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pei Chun Chen
CEO | Chief Executive Officer | - | 19-02-28 |
Wan Tzu Chang
DFI | Director of Finance/CFO | - | 19-04-07 |
Wei Yi Chou
CTO | Chief Tech/Sci/R&D Officer | - | 19-05-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kuo Pin Kao
BRD | Director/Board Member | - | 13-03-27 |
Wan Lai Cheng
BRD | Director/Board Member | - | 11-05-17 |
Sandy Lee
BRD | Director/Board Member | - | 19-08-14 |
Chun Hung Chen
BRD | Director/Board Member | 69 | 06-06-19 |
Man Chin Ku
BRD | Director/Board Member | - | 13-06-23 |
Chia Ling Lin
BRD | Director/Board Member | - | 19-08-14 |
Shu Hsuan Tsai
BRD | Director/Board Member | - | 17-06-14 |
Yue Sheng Tsai
BRD | Director/Board Member | - | 19-08-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 205,817,200 | 97,833,200 ( 47.53 %) | 0 | 47.53 % |
Company contact information
![address Mycenax Biotech Inc.(4726)](https://cdn.zonebourse.com/static/address/16180747.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+66.67% | 376M | |
+20.66% | 126B | |
+24.43% | 27.95B | |
-19.97% | 20.5B | |
-15.92% | 17.12B | |
-18.36% | 16.1B | |
-46.67% | 14.97B | |
+11.84% | 14.84B | |
+59.29% | 14.38B | |
+148.85% | 12.37B |
- Stock Market
- Equities
- 4726 Stock
- Company Mycenax Biotech Inc.